Cargando…

Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy

BACKGROUND: M-type phospholipase A2 receptor (PLA2R) is the first autoantigen responsible for idiopathic membranous nephropathy (IMN). However, serum PLA2R antibody (PLA2R-Ab) can be inaccurate in distinguishing between IMN and secondary membranous nephropathy, while renal PLA2R antigen (PLA2R-Ag) e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qiu-hua, Wu, Mian, Hu, Zhi-gang, Liu, Xiao-bin, Huang, Biao, Zhang, Yi, Liu, Bin, Zhu, Yu-shan, Wang, Liang, Sun, Zhu-xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232673/ https://www.ncbi.nlm.nih.gov/pubmed/32461964 http://dx.doi.org/10.1155/2020/1693710

Ejemplares similares

Antiphospholipase A(2) Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
por: Behnert, Astrid, et al.
Publicado: (2014)

Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy
por: Zhang, Yi, et al.
Publicado: (2022)

Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
por: Obrisca, Bogdan, et al.
Publicado: (2015)

Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy
por: Rodas, Lida M, et al.
Publicado: (2018)

Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody
por: Cui, Hao-yuan, et al.
Publicado: (2021)

A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor
por: Zhang, Qiuhua, et al.
Publicado: (2019)

Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity
por: Liu, Wenbin, et al.
Publicado: (2020)

The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy
por: Duan, Suyan, et al.
Publicado: (2023)

Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy
por: Lönnbro-Widgren, Jennie, et al.
Publicado: (2015)

Screening of Medications for Idiopathic Membranous Nephropathy Using Glomerular Whole-Genome Sequencing
por: Hou, Yawei, et al.
Publicado: (2022)

Glomerular Endothelial Cell Injury and Focal Segmental Glomerulosclerosis Lesion in Idiopathic Membranous Nephropathy
por: Morita, Megumi, et al.
Publicado: (2015)

Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy
por: Zhang, Qiuhua, et al.
Publicado: (2017)

Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis
por: Li, Weiying, et al.
Publicado: (2018)

Advances of the experimental models of idiopathic membranous nephropathy
por: Jiang, Han Xue, et al.
Publicado: (2020)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
por: Sun, Yuemeng, et al.
Publicado: (2022)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy
por: Dong, Lei, et al.
Publicado: (2022)

Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy
por: Zhang, Chengning, et al.
Publicado: (2020)

Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
por: Cheong, Jamie, et al.
Publicado: (2018)

Synthesis, Antiphospholipase A(2), Antiprotease, Antibacterial Evaluation and Molecular Docking Analysis of Certain Novel Hydrazones
por: El-Sayed, Nahed N. E., et al.
Publicado: (2016)

Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis
por: Dai, Huanzi, et al.
Publicado: (2015)

The continual presence of C3d but not IgG glomerular capillary deposition in stage I idiopathic membranous nephropathy in patients receiving corticosteroid treatment
por: Zhang, Rui, et al.
Publicado: (2012)

The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and Membranous Nephropathy
por: Bu, Lihong, et al.
Publicado: (2023)

Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression
por: An, Xiaofei, et al.
Publicado: (2017)

Anti-glomerular basement membrane disease with IgA nephropathy: A case report
por: Guo, Chuan, et al.
Publicado: (2022)

Differential Expression of Urinary Exosomal Small RNAs in Idiopathic Membranous Nephropathy
por: Zhang, Jinshi, et al.
Publicado: (2020)

Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy
por: Xu, Ning-Xin, et al.
Publicado: (2017)

Single-Nephron GFR in Different Glomerular Basement Membrane Stages of Membranous Nephropathy
por: Okabayashi, Yusuke, et al.
Publicado: (2023)

How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?
por: Feng, Zhendong, et al.
Publicado: (2020)

Serum metabolomics analysis reveals metabolite profile and key biomarkers of idiopathic membranous nephropathy
por: Ye, Mingjun, et al.
Publicado: (2023)

Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction
por: Wang, Peiheng, et al.
Publicado: (2023)

Synthesis and evaluation of anticancer, antiphospholipases, antiproteases, and antimetabolic syndrome activities of some 3H-quinazolin-4-one derivatives
por: El-Sayed, Nahed N. E., et al.
Publicado: (2019)

Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
por: Liang, Jinxiu, et al.
Publicado: (2023)

Urinary peptidomics reveals proteases involved in idiopathic membranous nephropathy
por: Lin, Baoxu, et al.
Publicado: (2021)

Clinical manifestations of IgA nephropathy combined with thin glomerular basement membrane nephropathy in children
por: Ju Hwang, Young, et al.
Publicado: (2013)

The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy
por: Dong, Zhaocheng, et al.
Publicado: (2020)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mq8gmnit9e5arnulhqjbnvndf2